ESR1 and cancer: Interestingly, AR (or ESR1) silencing also blocked SG formation after ARPI (or ERPI) stress in prostate (and breast) cancer cells, highlighting a role for AR and ESR1 mRNA in triggering SGs when its receptor is antagonised.